TY - JOUR
T1 - World health organization high priority pathogens
T2 - Ophthalmic disease findings and vision health perspectives
AU - Kuthya, Sanjana
AU - Anthony, Casey L.
AU - Fashina, Tolulope
AU - Yeh, Steven
AU - Shantha, Jessica G.
N1 - Funding Information:
Funding: This project was supported by unrestricted departmental grant from Research to Prevent Blindness, Inc. to the Emory Eye Center, Emory University School of Medicine, National Eye Institute/ National Institutes of Health core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine), National Eye Institute of the National Institutes of Health under award number K23 EY030158 (Shantha) and R01 EY029594 (Yeh). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Funding support is also provided by the Macula Society Retina Research Foundation Cox Family Grant, Bayer Global Ophthalmology Awards Program, the Association for Research in Vision and Ophthalmology Mallinckrodt Foundation Young Investigator Award (Yeh), Santen, Inc, the Stanley M. Truhlsen Family Foundation, Inc., and the Sitaraman Family Foundation.
Funding Information:
This project was supported by unrestricted departmental grant from Research to Prevent Blindness, Inc. to the Emory Eye Center, Emory University School of Medicine, National Eye Institute/ National Institutes of Health core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine), National Eye Institute of the National Institutes of Health under award number K23 EY030158 (Shantha) and R01 EY029594 (Yeh). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Funding support is also provided by the Macula Society Retina Research Foundation Cox Family Grant, Bayer Global Ophthalmology Awards Program, the Association for Research in Vision and Ophthalmology Mallinckrodt Foundation Young Investigator Award (Yeh), Santen, Inc, the Stanley M. Truhlsen Family Foundation, Inc., and the Sitaraman Family Foundation.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/4
Y1 - 2021/4
N2 - Recent Ebola epidemics, the ongoing COVID-19 pandemic, and emerging infectious disease threats have highlighted the importance of global infectious diseases and responses to public health emergencies. Ophthalmologists are essential health care workers who provide urgent and emergent vision care services during outbreaks and address the ocular consequences of epidemic and pandemic infectious diseases. In 2017, theWorld Health Organization (WHO) identified high priority pathogens likely to cause a future epidemic with the goal of guiding research and development to improve diagnostic tests, vaccines, and medicines. These measures were necessary to better inform and respond to public health emergencies. Given the ocular complications associated with emerging infectious diseases, there is a need to recognize the ophthalmic sequelae for future vision health preparedness for potential future outbreaks. The WHO High Priority pathogens list provides a roadmap for ophthalmologists and subspecialty providers that will guide strategic areas of research for clinical care and preparedness for future pandemic threats. This review summarizes these key viral pathogens, summarizes major systemic disease findings, and delineates relevant ocular complications of the WHO High Priority pathogens list, including Crimean-Congo hemorrhagic fever, Filovirus diseases (Ebola virus disease and Marburg hemorrhagic fever), human Coronaviruses, Lassa Fever, Nipah virus infection, Zika, and Rift Valley fever.
AB - Recent Ebola epidemics, the ongoing COVID-19 pandemic, and emerging infectious disease threats have highlighted the importance of global infectious diseases and responses to public health emergencies. Ophthalmologists are essential health care workers who provide urgent and emergent vision care services during outbreaks and address the ocular consequences of epidemic and pandemic infectious diseases. In 2017, theWorld Health Organization (WHO) identified high priority pathogens likely to cause a future epidemic with the goal of guiding research and development to improve diagnostic tests, vaccines, and medicines. These measures were necessary to better inform and respond to public health emergencies. Given the ocular complications associated with emerging infectious diseases, there is a need to recognize the ophthalmic sequelae for future vision health preparedness for potential future outbreaks. The WHO High Priority pathogens list provides a roadmap for ophthalmologists and subspecialty providers that will guide strategic areas of research for clinical care and preparedness for future pandemic threats. This review summarizes these key viral pathogens, summarizes major systemic disease findings, and delineates relevant ocular complications of the WHO High Priority pathogens list, including Crimean-Congo hemorrhagic fever, Filovirus diseases (Ebola virus disease and Marburg hemorrhagic fever), human Coronaviruses, Lassa Fever, Nipah virus infection, Zika, and Rift Valley fever.
KW - Anterior uveitis
KW - COVID-19
KW - Ebola survivor
KW - Ebola virus disease
KW - Emerging infectious disease
KW - Marburg virus disease
KW - Ophthalmic manifestations
KW - Ophthalmic sequalae
KW - Posterior uveitis
KW - Retinitis
KW - Tear film transmission
KW - Uveitis
KW - Viral persistence
UR - http://www.scopus.com/inward/record.url?scp=85104541585&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104541585&partnerID=8YFLogxK
U2 - 10.3390/pathogens10040442
DO - 10.3390/pathogens10040442
M3 - Review article
C2 - 33917710
AN - SCOPUS:85104541585
SN - 2076-0817
VL - 10
JO - Pathogens
JF - Pathogens
IS - 4
M1 - 442
ER -